Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
FHTX
FHTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
FHTX News
Foghorn Therapeutics Appoints New CFO
Feb 23 2026
seekingalpha
Foghorn Therapeutics to Participate in Biotech Summit
Feb 03 2026
Newsfilter
Atossa Therapeutics Receives FDA Orphan Drug Designation, Stock Rises Nearly 13%
Jan 20 2026
NASDAQ.COM
Oncolytics Biotech Accelerates Cancer Treatment with New Executive Appointments
Jan 14 2026
Newsfilter
Oncolytics Biotech Accelerates Cancer Treatment Progress, Aiming for FDA Approval in 2026
Jan 14 2026
PRnewswire
Foghorn Therapeutics Raises $50 Million to Advance Cancer Treatments
Jan 10 2026
Globenewswire
Foghorn Therapeutics Raises $50 Million to Advance Cancer Treatments
Jan 10 2026
Newsfilter
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4
Dec 11 2025
Newsfilter
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 at 10μg/kg/day
Dec 11 2025
PRnewswire
Stifel Nicolaus Begins Coverage of Foghorn Therapeutics, Assigns Buy Rating and $12 Price Target
Dec 04 2025
Yahoo Finance
Aardvark Therapeutics Analyst Starts Coverage Optimistically; Check Out the Top 3 Initiations for Friday
Nov 07 2025
Benzinga
Foghorn Therapeutics Set to Attend Three Upcoming Investor Conferences
Nov 03 2025
Newsfilter
Foghorn Therapeutics Reports Major Advancements for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit
Oct 16 2025
Newsfilter
IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies
Aug 28 2025
PRnewswire
Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering
Aug 11 2025
Newsfilter
Flagship Pioneering Unveils Terrana Biosciences to Deliver Adaptive, Targeted Agricultural Solutions through a Novel RNA Technology Platform
Jul 01 2025
Newsfilter
Show More News
